Insiders who have reported open-market trades at the same companies as Jaime Vieser. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jaime Vieser is a corporate insider, tracked as Director of Alaunos Therapeutics, Inc. (TCRT). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jaime Vieser submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jaime Vieser been buying or selling stock?
Recorded transactions: 3 open-market purchases ($1K) and 0 open-market sales across all tracked filings.
Jaime Vieser is Director of Alaunos Therapeutics, Inc. (TCRT). 11 SEC Form 4 filings on record going back to 2024, most recently on 8 October 2026. Lifetime open-market purchases: $1K.
Recent transactions
9
The latest 9 SEC Form 4 transactions reported by Jaime Vieser.
InsiderAlpha's records for Jaime Vieser go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. The typical open-market purchase is $1K (1 of 3 buys carry a usable dollar value, totaling $1K). The largest single buy on record is $1K of TCRT in 2025. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
